• 83
  • 11
  • Favorite

U.S. funding to now cover study of Novavax's COVID-19 shot in adolescents

Reuters2022-02-08

Feb 7 (Reuters) - Novavax Inc(said on Monday U.S. government funding for its COVID-19 vaccine had been expanded to cover a late-stage study in adolescents with a booster component.

Novavax in July 2020 had received $1.6 billion in funding to develop its protein-based vaccine under a government program aimed at accelerating access to coronavirus vaccines and treatments, formerly called Operation Warp Speed.

The company late last month filed for emergency use authorization of the vaccine for U.S. adults, a long-awaited step following months of struggles with development and manufacturing problems.

Novavax's two-dose shot has received authorizations from the European Union and the World Health Organization and was recently cleared for use in adults in Britain and New Zealand.

Novavax last year started testing its vaccine in adolescents aged 12 to 17.

Currently, rival Pfizer and its partner BioNTech's COVID-19 vaccine is the only one cleared for individuals in that age group in the United States. The U.S. Food and Drug Administration in January also authorized a booster shot of the companies' vaccine for those 12 years and older.

Novavax in December said receiving an additional booster dose of its vaccine further increased people's immune response to Omicron. The company cited data from ongoing studies of its vaccine's effectiveness in adolescents and as a booster.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment11

  • jimmylaw
    ·2022-02-08
    Like comment 
    Reply
    Report
  • Jellywonka
    ·2022-02-08
    Ok
    Reply
    Report
  • Eyes Closed
    ·2022-02-08
    But for how long will all these truly last...
    Reply
    Report
  • Dinesh27
    ·2022-02-08
    Pls like!
    Reply
    Report
  • phongy 45
    ·2022-02-08
    Good feedback
    Reply
    Report
  • Tiger Lim
    ·2022-02-08
    Good
    Reply
    Report
  • Victorhc88
    ·2022-02-08
    Like 
    Reply
    Report
  • V K
    ·2022-02-08
    Pls like tyvm[Happy] 
    Reply
    Report
  • STSL
    ·2022-02-08
    Ok
    Reply
    Report
  • US_watchlist
    ·2022-02-08
    Please like and comment. Thanks
    Reply
    Report
  • AhBart
    ·2022-02-08
    A friend in need is a friend indeed 💪🏽
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial